Recalls affecting New Mexico
Notices that name New Mexico in their distribution area, plus every nationwide recall — nationwide recalls reach New Mexico too.
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Mylan Pharmaceuticals Inc Prasugrel Tablets, USP, 10mg recall: Failed Dissolution Specifications; product failed to meet 18-month stability
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
-
Class II · last month
Sage Products, LLC 2% Chlorhexidine Gluconate* Cloth, Non-sterile recall: Cross Contamination with Other Products
Cross Contamination with Other Products
-
Class II · last month
Baxter Healthcare Corporation Vasopressin, in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Vancomycin Injection, USP, in 0.9% Sodium Chloride recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Famotidine Injection in Sodium Chloride Injection, 20 mg recall: CGMP Deviations
CGMP Deviations
-
Class III · last month
Bionpharma Inc. Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class II · last month
Baxter Healthcare Corporation Myxredlin, Insulin Human in 0.9% Sodium Chloride recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Allies Group Inc. THE ONE SPF 50 Invisible Sunscreen GEL, , 20ml - 0.7 fl. oz. Tube recall: Subpotent Product: Firm Testing indicated the affected product
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
-
Class II · last month
Baxter Healthcare Corporation Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Allies Group Inc. THE ONE SPF 50 Invisible Sunscreen GEL, , 50ML - 1.7 fl. oz Tube recall: Subpotent Product: Firm Testing indicated the affected product
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Nexterone , 360 mg/200 mL in Galaxy Single-Dose recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Daptomycin, in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Pantoprazole Sodium in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Allies Group Inc. THE ONE SPF 50 Invisible Sunscreen GEL, , 90ml - 3 fl. oz. Tube recall: Subpotent Product: Firm Testing indicated the affected product
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
-
Class II · last month
Allies Group Inc. THE ONE SPF 50 Invisible Sunscreen GEL, , 3ml - 0.1 fl. oz recall: Subpotent Product: Firm Testing indicated the affected product
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
-
Class II · last month
Teva Pharmaceuticals USA, Inc traZODone Hydrochloride Tablets, USP, 50 mg recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class III · last month
American Health Packaging Buprenorphine Sublingual Tablets , 2 mg, 30 Tablets recall: Labeling: Label Mix-up
Labeling: Label Mix-up
-
Class III · last month
Supernus Pharmaceuticals, Inc. Trokendi XR, extended-release capsules, 50 mg recall: Failed dissolution specifications
Failed dissolution specifications.
-
Class II · last month
Baxter Healthcare Corporation Cardene IV in 0.83% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
-
Class I · last month
Optimal Balance Pharmacy Glutathione 200 mg/mL, 30 mL sterile multidose vial recall: Microbial Contamination of Sterile Products - out of specifications results
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
-
Class II · last month
Baxter Healthcare Corporation Daptomycin, in 0.9% Sodium Chloride Injection, 1 recall: CGMP Deviations
CGMP Deviations